{
  "name": "Overview of Adverse Events",
  "id": "FDA-AE-T06",
  "version": 1,
  "description": "An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. [ICH E2]",
  "mainListOfContents": {
    "name": "List of Planned Analyses",
    "label": "LOPA",
    "contentsList": {
      "listItems": [
        {
          "name": "Overview of Adverse Events",
          "level": 1,
          "order": 1,
          "outputId": "Out_04",
          "sublist": {
            "listItems": [
              {
                "name": "Summary of Subjects by Treatment",
                "level": 2,
                "order": 1,
                "analysisId": "An_30"
              },
              {
                "name": "SAE [3]",
                "level": 2,
                "order": 2,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_31"
                    },
                    {
                      "name": "Comparison of subjects with any SAE, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_32"
                    },
                    {
                      "name": "Comparison of subjects with any SAE, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_32_1"
                    }
                  ]
                }
              },
              {
                "name": "Results in Death",
                "level": 2,
                "order": 3,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE that Results in Death by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_33"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Results in Death, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_34"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Results in Death, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_34_1"
                    }
                  ]
                }
              },
              {
                "name": "Is Life Threatening",
                "level": 2,
                "order": 4,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE that Is Life Threatening by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_35"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Is Life Threatening, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_36"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Is Life Threatening, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_36_1"
                    }
                  ]
                }
              },
              {
                "name": "Requires or Prolongs Hospitalization",
                "level": 2,
                "order": 5,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE that Requires or Prolongs Hospitalization by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_37"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_38"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_38_1"
                    }
                  ]
                }
              },
              {
                "name": "Persist or Significant Disability/Incapacity",
                "level": 2,
                "order": 6,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE that Persist or Significant Disability/Incapacity by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_39"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that involves Persist or Significant Disability/Incapacity, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_40"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that involves Persist or Significant Disability/Incapacity, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_40_1"
                    }
                  ]
                }
              },
              {
                "name": "Congenital Anomaly or Birth Defect",
                "level": 2,
                "order": 7,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any SAE that involves Congenital Anomaly or Birth Defect by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_41"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_42"
                    },
                    {
                      "name": "Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_42_1"
                    }
                  ]
                }
              },
              {
                "name": "Other",
                "level": 2,
                "order": 8,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with any Other SAE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_43"
                    },
                    {
                      "name": "Comparison of subjects with any Other SAE, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_44"
                    },
                    {
                      "name": "Comparison of subjects with any Other SAE, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_44_1"
                    }
                  ]
                }
              },
              {
                "name": "AE leading to permanent discontinuation of study drug",
                "level": 2,
                "order": 9,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with AE leading to permanent discontinuation of study drug, by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_45"
                    },
                    {
                      "name": "Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_46"
                    },
                    {
                      "name": "Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_46_1"
                    }
                  ]
                }
              },
              {
                "name": "AE leading to dose modification of study drug",
                "level": 2,
                "order": 10,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with AE leading to dose modification of study drug, by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_47"
                    },
                    {
                      "name": "Comparison of subjects with AE leading to dose modification of study drug, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_48"
                    },
                    {
                      "name": "Comparison of subjects with AE leading to dose modification of study drug, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_48_1"
                    }
                  ]
                }
              },
              {
                "name": "Any AE [4]",
                "level": 2,
                "order": 11,
                "sublist": {
                  "listItems": [
                    {
                      "name": "Summary of subjects with Any AE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_49"
                    },
                    {
                      "name": "Comparison of subjects with Any AE, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_50"
                    },
                    {
                      "name": "Comparison of subjects with Any AE, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_50_1"
                    }
                  ]
                }
              }
            ]
          }
        }
      ]
    }
  },
  "otherListsOfContents": [
    {
      "name": "List of Planned Outputs",
      "label": "LOPO",
      "contentsList": {
        "listItems": [
          {
            "name": "Overview of Adverse Events",
            "level": 1,
            "order": 1,
            "outputId": "Out_04"
          }
        ]
      }
    }
  ],
  "terminologyExtensions": [
    {
      "id": "TermEx01",
      "sponsorTerms": [
        {
          "id": "TermEx01_01",
          "submissionValue": "POPULATION SUMMARY",
          "description": "Summary statistics describing the study population(s)."
        }
      ],
      "enumeration": "AnalysisPurposeEnum"
    }
  ],
  "analysisOutputCategorizations": [
    {
      "id": "ANSET",
      "categories": [
        {
          "id": "ANSET_01",
          "label": "Safety",
          "subCategorizations": [
            {
              "id": "ANSET_01_ANINT",
              "categories": [
                {
                  "id": "ANSET_01_ANINT_05",
                  "label": "Adverse Events"
                }
              ],
              "label": "Safety Analysis Of Interest"
            }
          ]
        }
      ],
      "label": "Analysis Sets"
    }
  ],
  "analysisSets": [
    {
      "name": "Safety Population",
      "description": "All patients randomized and known to have taken at least one dose of randomized drug.",
      "id": "AnalysisSet_01",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADSL",
        "variable": "SAFFL",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    }
  ],
  "dataSubsets": [
    {
      "name": "Any SAE",
      "label": "SAE [3]",
      "id": "Dss_07",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESER",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Results in Death",
      "label": "Results in Death",
      "id": "Dss_08",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESDTH",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Is Life Threatening",
      "label": "Is Life Threatening",
      "id": "Dss_09",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESLIFE",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Requires or Prolongs Hospitalization",
      "label": "Requires or Prolongs Hospitalization",
      "id": "Dss_10",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESHOSP",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that involves Persist or Significant Disability / Incapacity",
      "label": "Persist or Significant Disability / Incapacity",
      "id": "Dss_11",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESDISAB",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that involves Congenital Anomaly or Birth Defect",
      "label": "Congenital Anomaly or Birth Defect",
      "id": "Dss_12",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESCONG",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "Other SAE",
      "label": "Other [4]",
      "id": "Dss_13",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "OR",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESMIE",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESCAN",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 3,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESOD",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          }
        ]
      }
    }
    ],
  "@type": "ReportingEvent"
}
